Skip navigation
Skip navigation

Bilateral trade agreements as drivers of national and transnational benefit from health technology policy: implications of recent US deals for Australian negotiations with China and India

Shats, Katherine; Faunce, Thomas

Description

This article compares controversial health technology provisions in two important United States free trade agreements with developed nations: Australia and with South Korea. It examines the multinational corporate forces behind the medicines and medical devices components of these texts and their likely impacts upon Australian trade negotiations with China and India. It also examines the implications of some recent changes to US trade policy for this area in subsequent bilateral deals such as...[Show more]

dc.contributor.authorShats, Katherine
dc.contributor.authorFaunce, Thomas
dc.date.accessioned2015-12-10T22:39:19Z
dc.identifier.issn1035-7718
dc.identifier.urihttp://hdl.handle.net/1885/57117
dc.description.abstractThis article compares controversial health technology provisions in two important United States free trade agreements with developed nations: Australia and with South Korea. It examines the multinational corporate forces behind the medicines and medical devices components of these texts and their likely impacts upon Australian trade negotiations with China and India. It also examines the implications of some recent changes to US trade policy for this area in subsequent bilateral deals such as that with Peru. This article argues it is important that the Australian government change policy and, like the present Congress in the United States, now systematically approach such impending trade agreements with a view to assisting the partners' regulatory frameworks to maximally enhance national and transnational benefit from their medicines and biotechnology industries.
dc.publisherCarfax Publishing, Taylor & Francis Group
dc.sourceAustralian Journal of International Affairs
dc.subjectKeywords: bilateral agreement; biotechnology; free trade; high technology industry; regulatory framework; trade agreement; trade reform; Asia; Australasia; Australia; China; Eurasia; Far East; India; Korea; North America; South Asia; South Korea; United States
dc.titleBilateral trade agreements as drivers of national and transnational benefit from health technology policy: implications of recent US deals for Australian negotiations with China and India
dc.typeJournal article
local.description.notesImported from ARIES
local.identifier.citationvolume62
dc.date.issued2008
local.identifier.absfor119999 - Medical and Health Sciences not elsewhere classified
local.identifier.ariespublicationu9507981xPUB387
local.type.statusPublished Version
local.contributor.affiliationFaunce, Thomas, ANU College of Law, ANU
local.contributor.affiliationShats, Katherine, ANU College of Law, ANU
local.description.embargo2037-12-31
local.bibliographicCitation.issue2
local.bibliographicCitation.startpage196
local.bibliographicCitation.lastpage213
local.identifier.doi10.1080/10357710802060550
dc.date.updated2015-12-09T10:49:50Z
local.identifier.scopusID2-s2.0-45949096433
local.identifier.thomsonID000257285600006
CollectionsANU Research Publications

Download

File Description SizeFormat Image
01_Faunce_Bilateral_trade_agreements_as_2008.pdf148.63 kBAdobe PDF    Request a copy


Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.

Updated:  20 July 2017/ Responsible Officer:  University Librarian/ Page Contact:  Library Systems & Web Coordinator